J 2015

Positive Influence of Being Overweight/Obese on Long Term Survival in Patients Hospitalised Due to Acute Heart Failure

LITTNEROVÁ, Simona; Jiří PAŘENICA; Jindřich ŠPINAR; Jiří VÍTOVEC; Ales LINHART et al.

Základní údaje

Originální název

Positive Influence of Being Overweight/Obese on Long Term Survival in Patients Hospitalised Due to Acute Heart Failure

Autoři

LITTNEROVÁ, Simona; Jiří PAŘENICA; Jindřich ŠPINAR; Jiří VÍTOVEC; Ales LINHART; Petr WIDIMSKÝ; Jiří JARKOVSKÝ ORCID; Roman MIKLÍK; Lenka ŠPINAROVÁ; Kamil ZEMAN; Jan BELOHLAVEK; Filip MALEK; Marián FELŠŐCI; Jiří KETTNER; Petr OSTADAL; Cestmir CIHALIK; Jiří ŠPÁC; Hikmet AL-HITI; Marian FEDORCO; Richard FOJT; Andreas KRUGER; Josef MALEK; Tereza MIKUŠOVÁ; Zdenek MONHART; Stanislava BOHACOVA; Lidka POHLUDKOVA; Filip ROHAC; Jan VACLAVIK; Dagmar VONDRAKOVA; Klaudia VYSKOČILOVÁ; Miroslav BAMBUCH a Ladislav DUŠEK

Vydání

Plos one, San Francisco, Public Library of Science, 2015, 1932-6203

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.057

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/15:00085555

Organizační jednotka

Lékařská fakulta

UT WoS

000350683900023

EID Scopus

2-s2.0-84923372902

Klíčová slova anglicky

BODY-MASS INDEX; ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; OBESITY PARADOX; RISK-FACTORS; MORTALITY; ASSOCIATION; REGISTRY; ADIPOCYTOKINE; GUIDELINES

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 5. 1. 2016 15:02, Soňa Böhmová

Anotace

V originále

Background Obesity is clearly associated with increased morbidity and mortality rates. However, in patients with acute heart failure (AHF), an increased BMI could represent a protective marker. Studies evaluating the "obesity paradox" on a large cohort with long-term follow-up are lacking. Methods Using the AHEAD database (a Czech multi-centre database of patients hospitalised due to AHF), 5057 patients were evaluated; patients with a BMI <18.5 kg/m(2) were excluded. All cause mortality was compared between groups with a BMI of 18.5-25 kg/m(2) and with BMI >25 kg/m(2). Data were adjusted by a propensity score for 11 parameters. Results In the balanced groups, the difference in 30-day mortality was not significant. The long-term mortality of patients with normal weight was higher than for those who were overweight/obese (HR, 1.36; 95% CI, 1.26-1.48; p<0.001)). In the balanced dataset, the pattern was similar (1.22; 1.09-1.39; p<0.001). A similar result was found in the balanced dataset of a subgroup of patients with de novo AHF (1.30; 1.11-1.52; p = 0.001), but only a trend in a balanced dataset of patients with acute decompensated heart failure. Conclusion These data suggest significantly lower long-term mortality in overweight/obese patients with AHF. The results suggest that at present there is no evidence for weight reduction in overweight/obese patients with heart failure, and emphasize the importance of prevention of cardiac cachexia.

Návaznosti

MUNI/A/1012/2013, interní kód MU
Název: Diagnostika akutní myokarditidy mimikující akutní infarkt myokardu s ST elevacemi
Investor: Masarykova univerzita, Diagnostika akutní myokarditidy mimikující akutní infarkt myokardu s ST elevacemi, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty